Eglonil. Litaelo tsa tšebeliso, litekanyetso li behoa 'me contraindications

The a sebetsang a ntho ho lokisetsa "Eglonil" ke sulpiride, benzamide neuroleptic le e leka-lekaneng neuroleptic mosebetsi. moemeli ena meriana e na le ka 'mele stimulant, antidepressant sebediswa.

"Eglonil" (mosebedisi lintlha) ka bohareng tsamaiso ea methapo thibela receptors dopaminergic tse sebakeng tsamaiso limbic. Ho fihlela lethal dose Optimum tsa phello antipsychotic sulpiride o moholo ho 600 mg,. Lethal dose ho 600 mg, e hlophisitsweng e le hore ho fumana e hlasimollang, bohato antidepressant.

Ka tekanyetso nyane sulpiride laolwa ekelletsa moo ka kalafo ya psychosomatic mafu botho ba hae. "Eglonil" thuto e bontša atleha ho fokotsa matšoao a mpe ea gastric seso. Bakuli ba ho teneha feela mantle a syndrome, ba nka sulpiride, ho fokotseha ka matla a bohloko ka mpeng.

Ka dosages tlaase Sulpiride (50-300 mg,) felisa ho tsekela.

"Eglonil": litaelo tsa tšebeliso

lithethefatsi e ho kopantswe le lithethefatsi tse ling tse etsang meriana psychotropic kapa sebelisoa e le monotherapy:

• ka bokuli ba ho kopana hlooho a hlobaetsang le a sa foleng;
• hlobaetsang delirious re;
• ho tepella maikutlo se hlahang ho yona tse sa tšoaneng;
• le ho tšoha, ho tšoenyeha, o ile a bontša ka ho bakuli ba batho ba baholo;
• le maloetse a matla boitshwaro ka bana ba ileng ba fihla ho lilemo tse tšeletseng, ho kopanyelletsa le autism (50 mg,).

"Eglonil": pukwanana dosing

tharollo

Ho ea tšoara hlobaetsang psychosis (hammoho le ka mokgwa foleng) abetsoe / limithara sulpiride ente ka litekanyetso li behoa ea ho tloha 400 mg, ho 800 mg,. Phekolo e reretsoe matsatsi a ho fihlela ho 14.

"Eglonil" pilisi

Ka maemo a ho a hlobaetsang le a sa foleng bokuli ba ho kopana hlooho, delirious tlhaselo psychosis, ho tepella maikutlo ngaka khethang lethal dose e le letsatsi le letsatsi ho tloha 200 mg, ho 1000 mg, arotsoe ka tekanyetso 2-3.

"Eglonil" komiki

Ea ho phekola ho tšoenyeha neurosis le maikutlo a batho ba baholo ba beuweng lithethefatsi lethal dose ea letsatsi le letsatsi libeke tse ho tloha 50 mg, ho 150 mg, ho fihlela ho 4.

Ka mafu a matla boitshwaro ka bana, autism balwa lethal dose ea letsatsi le letsatsi ka palo ea 5 mg, ka ho ya ka tse 1 kg 'mele oa boima ba' mele ho 10 mg, ka ho ya ka tse 1 kg.

Bakeng sa bakuli ba a fihla botsofaling, e lethal dose ya sulpiride ke ¼ ea tšimoloho ea kalafo, kapa ½ ea tloaelehile ae buelletseng lethal dose.

Ka phumano amanang, ho hloleha ho khetheha renal, ngaka ea ho fokotsa lethal dose hore eketsa karohano pakeng tsa tsamaiso.

"Eglonil": litla-morao

ditlolo khoneha tsamaisong endocrine: ntshetsopele ya hyperprolactinemia reversible, le hlahang galactorrhea, amenorrhea, disruptions matsatsing, ke ka seoelo haholo hlokomela matšoao a gynecomastia, ho hloka matla le frigidity. Ka linako tse ling bakuli ba tletleba ba fufuleloa ka tsela e feteletseng, ka ketsahalo ea boima ba 'mele ka tsela e feteletseng.

E eketsa mosebetsi oa enzyme sebete.

CNS Karabo ea ho nako e telele tšebeliso "eglonil": boroko, molikoalikoane, ho tremor, mathoasong dyskinesia.

Ikatisetsa bongaka, ho na le Maemong a sa tloaelehang tsa dyskinesia tardive, e leng e bontšoa ka mekhatlo involuntary ea leleme, sefahleho, ka mor'a hore tshebediso ya nako e telele, "Eglone".

Ha hyperthermia baeti ba fihlelang ho sulpiride hlakola hobane feberu e bontša monyetla oa ho fumanoe "neuroleptic bolaeang lefu" (CSN).

tsamaiso e khopo la pelo ka linako tse ling a leka ho baeti ba fihlelang ho "eglonil" tachycardia, phahameng khatello ea mali, ka seoelo haholo - ntshetsopele ya orthostatic hypotension, QT prolongation.

kulisa ba letlalo lekhopho.

Eglonil: amohele taeo (contraindications)

Sulpiride prolaktinzavisimymi contraindicated ka bakuli ba lihlahala, hyperprolactinemia, botahoa, ka mocheso oa takatso e matla, ferekane kelellong psychosis, le pheochromocytoma. U se ke ua nka "Eglonil" bo-'mè ba anyesang a.

Thibetsoe ka ho intravenous ente ea bana sulpiride tlasa dilemo tse 18 tsa lilemo, hammoho le mokete oa ba bana capsules tlasa lilemo tse 6.

Sa kgothaletswa ho kopantswe le sulpiride agonists tsa receptors dopaminergic le sultopride.

Meriana contraindicated le hypersensitivity ho e mong oa metsoako eo.